Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational study
Sogut et al., The American Journal of Emergency Medicine, doi:10.1016/j.ajem.2020.12.014
Sogut et al., Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational.., The American Journal of Emergency Medicine, doi:10.1016/j.ajem.2020.12.014
Dec 2020   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Safety study of 152 outpatients concluding that HCQ is safe for COVID-19, was well tolerated, and was not associated with a risk of ventricular arrhythmia due to drug-induced QTc interval prolongation.
Sogut et al., 11 Dec 2020, peer-reviewed, 10 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: Journal Pre-proof Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational study Ozgur Sogut, Mehmet Mustafa Can, Ramazan Guven, Onur Kaplan, Hüseyin Ergenc, Tuba Betül Ümit, Olgun Demir, Murat Kaya, Tarık Akdemir, Sümeyye Çakmak PII: S0735-6757(20)31133-5 DOI: https://doi.org/10.1016/j.ajem.2020.12.014 Reference: YAJEM 159639 To appear in: American Journal of Emergency Medicine Received date: 26 September 2020 Revised date: 3 December 2020 Accepted date: 6 December 2020 Please cite this article as: O. Sogut, M.M. Can, R. Guven, et al., Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational study, American Journal of Emergency Medicine (2018), https://doi.org/10.1016/ j.ajem.2020.12.014 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2018 Published by Elsevier. Journal Pre-proof Title: Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID19: A pilot observational study Running title: Safety and efficacy of hydroxychloroquine in outpatients with COVID-19 Order of Authors Ozgur Sogut1, Mehmet Mustafa Can2, Ramazan Guven3, Onur Kaplan1, Hüseyin Ergenc1, University of Health Sciences, Haseki Training and Research Hospital, Department of ro 1 of Tuba Betül Ümit1, Olgun Demir1, Murat Kaya1, Tarık Akdemir1, Sümeyye Çakmak4 Emergency Medicine, Istanbul, Turkey University of Health Sciences, Haseki Training and Research Hospital, Department of -p 2 3 re Cardiology, Istanbul, Turkey University of Health Sciences, Kanuni Sultan Suleyman Training and Research Hospital, University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital, na 4 lP Department of Emergency Medicine, Istanbul, Turkey Department of Emergency Medicine, Istanbul, Turkey Jo ur Emails of Authors Ozgur Sogut1, Email: ozgur.sogut@sbu.edu.tr Mehmet Mustafa Can2, mehmetmustafacan@yahoo.com Ramazan Guven3, drramazanguven@gmail.com Onur Kaplan1, kaplan2852@yahoo.com Hüseyin Ergenc1, mdergenc@gmail.com Tuba Betül Ümit1, tbumit@hotmail.com Olgun Demir1, olgundemir512@hotmail.com Murat Kaya1, dr.mkaya34@hotmail.com Tarık Akdemir1, tarikakdemir52@gmail.com 1 Journal Pre-proof Sümeyye Çakmak4, sumeyyetumturk@gmail.com Address for correspondence and reprint requests: Name: Ozgur Sogut Address: University of Health Sciences, Department of Emergency Medicine, Haseki Research and Training Hospital, Millet Street, Zip Code: 34096, Fatih/Istanbul, Turkey. of Phone: +90 (212) 312 84 56/24 06 ro E-mail: ozgur.sogut@sbu.edu.tr Jo ur na lP re -p Fax: +90 (212) 313 96 15 2 Journal Pre-proof Title: Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID19: A pilot observational study Running title: Safety and efficacy of hydroxychloroquine in outpatients with COVID-19 ABSTRACT Purpose: We investigated the efficacy and safety of hydroxychloroquine for..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit